Claims for Patent: 5,863,559

Summary for Patent: 5,863,559

Title:	Oral dosage form for treating migraine
Abstract:	A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient. The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
Inventor(s):	Phillips; Anthony John (Ware, GB3), Winterborn; Ian Keith (Mississauga, CA), Padfield; John Malcolm (Uxbridge, GB3)
Assignee:	Glaxo Group Limited (Greenford, GB2)
Application Number:	08/381,422
Patent Claims:	1. A pharmaceutical composition for oral administration comprising a compressed film-coated tablet comprising a tablet core containing 25 to 200 mg of 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide succinate (1:1) salt as active ingredient, and a pharmaceutically acceptable carrier or excipient and a film coating on said table core wherein the film coating is applied to the tablet core in an amount of from 2 to 5% w/w of the tablet. 2. A pharmaceutical composition as claimed in claim 1 in the form of a compression tablet. 3. A pharmaceutical composition as claimed in claim 1 wherein the film coating comprises a polymer. 4. A pharmaceutical composition as claimed in claim 3 wherein the polymer is hydroxypropyl methylcellulose. 5. A pharmaceutical composition as claimed in claim 1 wherein the composition comprises 50 to 100 mg of active ingredient. 6. A method of treating a man suffering from migraine which comprises administering the composition of claim 1 to the man.